As specified in our exclusive report, the global Direct-to-Consumer (DTC) Genetic Testing Market is projected to reach USD 4.1 billion by 2030.
The rising prevalence of rare genetic diseases is expected to drive market growth. Rising public awareness across the globe, along with the increasing demand for personalized care for genetic services, is expected to facilitate growth in the market. DTC genetic testing industry is fragmented in nature, with few major players and other small start-up companies providing superior quality DTC tests at low cost, which will solve the affordability issues and positively impact the market growth.
The variety of genetic tests has expanded throughout the years. Early forms of genetic testing, starting in the 1950s, involved counting the number of chromosomes per cell. In the 1970s, a method of staining specific regions of chromosomes was developed called chromosome banding, which allowed a more detailed analysis of chromosome structure and the diagnosis of genetic disorders involving large structural rearrangements.
Genetic testing is usually performed as part of genetic counseling, and as of mid-2008, more than 1,200 clinically applicable genetic tests were available. Once an individual decides to proceed with genetic testing, a medical geneticist, genetic counselor, primary care physician, or specialist may order the test after obtaining informed consent. Genetic testing is done on blood, hair, skin, amniotic fluid (the fluid that surrounds the fetus during pregnancy), or other tissue samples. For example, a medical procedure called a buccal smear uses a small brush or cotton swab to collect a sample of cells from the inner surface of the cheek.
Recent Development
January 2022: 3andMe Holding Co., a leading consumer genetics and research company, received FDA approval for a genetic health risk report on a genetic prostate cancer marker.
Which Region Holds the Largest Share?
North America holds the largest market share over the forecast period. Changing consumer attitudes towards genetic testing and rising costs. The substantial amount of disposable income allows consumers to spend more on direct-to-consumer genetic testing such as parenteral and nutritional testing as well as on ongoing projects that will fuel the market in the North American region.
Some of the key players in the direct-to-consumer genetic testing market are:
23andMe, Inc., EasyDNA, Family Tree DNA, Full Genome Corporation Inc., Ancestry, Color Genomics, Helix OpCo LLC, Mapmygenome, Identigene, Pathway genomics, Karmagenes SA, Living DNA Ltd., Genesis Healthcare Co., The SkinDNA Company Pty Ltd, MyHeritage, 24 Genetics, DNA Forensics Laboratory Pvt. Ltd., DNA Diagnostic Center.
About Us
Market Business Insights is a leading global market research and consulting firm. We focus on business consulting, industry chain research, and consumer research to help customers provide non-linear revenue models. We believe that quality is the soul of the business and that is why we always strive for high-quality products. Over the years, with our efforts and support from customers, we have collected inventive design methods in various high-quality market research and research teams with extensive experience.